VONSECA 20 MG 14TABS

ABOUT VONOPRAZAN: FIRST-IN-CLASS POTASSIUM-COMPETITIVE ACID BLOCKER MECHANISM OF ACTION OF VONOPRAZAN: A NOVEL MECHANISM OF ACTION CALLED POTASSIUM-COMPETITIVE ACID BLOCKERS (P-CABS) WHICH COMPETITIVELY INHIBITS THE BINDING OF POTASSIUM IONS TO H+ K+-ATPASE (ALSO KNOWN AS THE PROTON PUMP) IN THE FINAL STEP OF GASTRIC ACID SECRETION IN GASTRIC PARIETAL CELLS. VONOPRAZAN FUMARATE HAS FAST-ACTING STRONG AND SUSTAINED ACID SECRETION INHIBITORY EFFECTS. INDICATIONS: - GASTRIC ULCER DUODENAL ULCER REFLUX ESOPHAGITIS PREVENTION OF RECURRENCE OF GASTRIC OR DUODENAL ULCER DURING LOW-DOSE ASPIRIN ADMINISTRATION PREVENTION OF RECURRENCE OF GASTRIC OR DUODENAL ULCER DURING NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) ADMINISTRATION - ADJUNCT TO HELICOBACTER PYLORI ERADICATION IN THE FOLLOWING SETTINGS: GASTRIC ULCER DUODENAL ULCER GASTRIC MUCOSA-ASSOCIATED LYMPHATIC TISSUE (MALT) LYMPHOMA IDIOPATHIC THROMBOCYTOPENIC PURPURA THE STOMACH AFTER ENDOSCOPIC RESECTION OF EARLY STAGE GASTRIC CANCER OR HELICOBACTER PYLORI GASTRITIS